학술논문
Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial
Document Type
Article
Author
Source
In The Lancet HIV January 2016 3(1):e13-e22
Subject
Language
ISSN
2352-3018